Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Screening for new agents.

B Oberg1, L Vrang

  • 1Department of Virology, Karolinska Institute, Stockholm, Sweden.

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|July 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The patient enablement instrument for back pain: reliability, content validity, construct validity and responsiveness.

Health and quality of life outcomes·2021
Same author

Lower extremity muscle strength in soccer players.

Clinical biomechanics (Bristol, Avon)·2013
Same author

Tibial translation and muscle activation during rehabilitation exercises 5 weeks after anterior cruciate ligament reconstruction.

Scandinavian journal of medicine & science in sports·2009
Same author

Parent's conceptions of intensive group training. The case of cerebral palsy.

Disability and rehabilitation·2009
Same author

Predictive factors for arm pain, neck pain, neck specific disability and health after anterior cervical decompression and fusion.

Acta neurochirurgica·2005
Same author

Descriptions of functioning and health and relations to a gross motor classification in adults with cerebral palsy.

Disability and rehabilitation·2004
Same journal

MUREAPLEXE: A multiplex recombinant antigen-based ELISA expanding the serological detection spectrum of urogenital mycoplasmas.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2026
Same journal

Three decades of neurocysticercosis mandatory notification in a Brazilian endemic region: clinical evolution and severity patterns.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2026
Same journal

Genomic landscape of 340 virulent Acinetobacter bacteriophages reveals anti-CRISPR-enriched candidates for therapeutic prioritization.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2026
Same journal

Nocardia antimicrobial susceptibility testing by microdilution: evaluation of ready-to-use plate including tedizolid and meropenem.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2026
Same journal

Consensus-based evaluation of RIDASCREEN<sup>®</sup> TB ELISA compared with two interferon-gamma release assays in a low-incidence setting.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2026
Same journal

A review of bloodstream infections-pathogens, pathogenesis, diagnostic strategies, treatment methods-challenges and future aspects.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2026
See all related articles

Developing new antiviral drugs involves screening for inhibitors of viruses like HIV and influenza. Current screening methods

Area of Science:

  • * Virology and drug discovery.
  • * Antiviral research and development.

Background:

  • * Focus on identifying inhibitors for key viruses: human immunodeficiency virus (HIV), herpesviruses, influenza virus, hepatitis B virus (HBV), and rhinovirus.
  • * Standard screening involves in vitro cell cultures followed by in vivo animal models.

Purpose of the Study:

  • * To evaluate the current state of antiviral drug screening methodologies.
  • * To address the uncertainty in predicting clinical efficacy from preclinical models.

Main Methods:

  • * Review of common screening approaches for antiviral agents.
  • * Analysis of the transition from cell culture to animal models in drug discovery.
  • * Consideration of clinical trial data for validation.

Related Experiment Videos

Main Results:

  • * Current screening methods' relevance for predicting clinical efficacy remains uncertain.
  • * Limited number of compounds evaluated in rigorous double-blind, placebo-controlled clinical trials hinders validation.
  • * Ongoing research is expanding the scope of antiviral drug development.

Conclusions:

  • * The predictive value of existing antiviral screening systems is expected to improve with increased research activity and data from clinical trials.
  • * Further validation through clinical trials is crucial for refining preclinical screening models.